FLGT FY 2018 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

FY 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$21M+14.0% YoY

Gross Profit

$11M49.9% margin

Operating Income

-$5M-23.7% margin

Net Income

-$6M-26.3% margin

EPS (Diluted)

$-0.25

Cash Flow

Operating Cash Flow

-$675,000

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$55M

Total Liabilities

$3M

Stockholders' Equity

$52M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$19M	+14.0%
Gross Profit	$11M	$10M	+4.8%
Operating Income	-$5M	-$3M	-45.6%
Net Income	-$6M	-$3M	-123.4%